About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Intravenous Beta-blockade for Improvement of Autonomic Activity

NCT00700466·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital Schleswig-Holstein

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients scheduled for coronary artery bypass surgery
Ejection fraction \> 30 %
Informed consent

You may not be if

Emergency cases
Myocardiac infraction within 4 weeks

The record

StatusCompleted

PhaseNo phase

Taking part100

StartedMar 2008

UpdatedJan 18, 2010

Conditions

Hypertension Tachycardia Heart Rate Variability

Where1

University Hospital Schleswig-Holstein, Campus Kiel, Germany
Kiel, Schleswig-Holstein, Germany

Clareo Health | Intravenous Beta-blockade for Improvement of Autonomic Activity